Dr.Max Polska
Dr.Max Polska operates 540+ franchise pharmacies across Poland, supported by ViaPharma wholesale distribution and online order fulfillment, serving roughly 9 million monthly customers and employing 4,000+ staff.
- Company typePrivate
- Founded2006
- HeadquartersWrocław, dolnośląskie, Poland
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Dr.Max Polska does
Dr.Max Polska (legal entity Dr. Max Sp. z o.o.) is a privately held Polish franchise pharmacy network headquartered in Wrocław, operating 540+ franchise pharmacies across Poland and serving roughly 9 million customers per month. The company runs an integrated stack comprising the franchise retail network, an in-house pharmaceutical wholesale operation branded ViaPharma(a) (with a distribution warehouse in Teresin), an online pharmacy with a dedicated order-fulfillment site in Łubna, and a corporate headquarters supporting HR, regional recruitment and franchise operations. It employs 4,000+ staff including pharmacists, pharmacy technicians, warehouse workers, online-fulfillment personnel and HQ functions.
The company's offerings to consumers include prescription and OTC medications, health consultations, preventive screenings and pharmacy-led community events (such as the 2025 'Przystanek Zdrowie' mobile health tour visiting 21 cities). To support workforce and franchise growth, Dr.Max runs structured programs including a six-month, 960-hour pharmacy internship, a relocation support package of up to 25,000 PLN, a flexible hourly work arrangement and an employee ambassador program ('Ambasadorzy na MAXa') covering 30 staff. Brand-side, the company maintains a careers website (kariera.drmax.pl), LinkedIn, Instagram and Facebook presence, and collaborates with partners such as La Roche-Posay, Novo Nordisk and Kaufland for community health initiatives.
The revenue model is a transaction-fee structure across three streams: (1) franchise pharmacy retail (RX/OTC sales through 540+ locations), (2) pharmaceutical wholesale distribution via ViaPharma supplying the network, and (3) e-commerce pharmacy orders with home delivery. The go-to-market relies on a franchise/recruitment-led motion (regional HR managers covering Polish voivodeships), combined with event-driven community engagement (mobile health screenings and school outreach). The company is a privately held Sp. z o.o. (private limited company) with a registered share capital of 11,340,000 PLN, and no public listing or disclosed external investor is identified in the input data.
Dr.Max Polska firmographics
Firmographics- Name
- Dr.Max Polska
- Legal name
- Dr. Max Sp. z o.o.
- Website
- https://kariera.drmax.pl
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Dr.Max Polska operates 540+ franchise pharmacies across Poland, supported by ViaPharma wholesale distribution and online order fulfillment, serving roughly 9 million monthly customers and employing 4,000+ staff.
- Ownership category
- akta.pro rank
Dr.Max Polska industry classification
Industry- Product category
- Retail Pharmacy
- NAICS
- Pharmacies and Drug Retailers (456110), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Retail & Community Pharmacies (Chain/Independent) (HLAFALAA)
- akta.pro secondary industries
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI), Pharmacy & Health Essentials Delivery (CRAFAFAI)
Keywords
Where Dr.Max Polska is headquartered
LocationHeadquarters
- HQ city
- Wrocław, dolnośląskie
- HQ country
- Poland
- HQ region
- Europe
Offices3 records
Markets served
Dr.Max Polska business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Pharmacy Retail Operations: Revenue generated from prescription (RX) and over-the-counter (OTC) product sales across 540+ franchise pharmacies serving 9 million monthly customers
- Pharmaceutical Wholesale: Distribution of pharmaceutical products through ViaPharm(a) wholesale operations supplying network pharmacies
- Online Pharmacy Sales: E-commerce operations for online medication and health product orders with delivery services
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Relocation package for pharmacy staff: up to 25,000 PLN total support |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Dr.Max Polska product offering
Product offeringCore offering
Dr.Max Polska operates a franchise pharmacy network of more than 540 locations across Poland, dispensing prescription and over-the-counter medications, providing health consultations, and selling health products directly to consumers. The network is supported by ViaPharma pharmaceutical wholesale operations and an integrated e-commerce platform for online medication orders with home delivery.
Product overview
Dr.Max Polska operates as a franchise pharmacy network offering pharmaceutical services through over 540 pharmacies across Poland. The company provides a comprehensive employment ecosystem including franchise pharmacy operations, online order fulfillment, pharmaceutical wholesale (ViaPharm), relocation support programs, structured internship opportunities, and flexible hourly work arrangements. The careers website (kariera.drmax.pl) serves as the primary digital platform for recruitment across pharmacy, headquarters, warehouse, and online operations divisions.
Differentiator
Problem solved
Functional benefit
Products and services
- Franchise Pharmacy Network (Sieć Aptek Franczyzowych Dr. Max) A network of over 540 franchise pharmacies operating across Poland, dispensing prescription (RX) and over-the-counter (OTC) pharmaceutical products and providing health consultations to the general public.
- Online Pharmacy (Zamówienia Online)
Quantifiable outcome
- 21 cities visited, 23000+ visitors, 2300+ health screenings conducted during 2025 Przystanek Zdrowie event
- +3 more outcomes
Companies that use Dr.Max Polska
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles2 records
Dr.Max Polska technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Dr.Max Polska partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- La Roche-PosaycoreCollaboration for Przystanek Zdrowie 2025 mobile health screening events. La Roche-Posay provided dermatological consultations and skin health expertise during the 21-city tour reaching 23,000+ visitors.
- Novo Nordisk (Porozmawiajmy szczerze o otyłości)minorHealth education partnership during Przystanek Zdrowie 2025 events, focusing on obesity awareness and health prevention messaging.
- KauflandminorRetail partner collaboration for Przystanek Zdrowie 2025 health screening events, providing venue space for mobile health consultations.
- Fundacja Nie Widać Po MnieminorCharitable foundation partnership for Przystanek Zdrowie 2025 events, supporting health education initiatives.
- ViaPharma (ViaPharm)corePharmaceutical wholesale distribution partner supplying Dr. Max pharmacy network with medications and health products. Justyna's team manages RX product introductions to ViaPharma warehouse and procurement for franchise pharmacies.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Dr.Max Polska competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Dr.Max Polska social profiles
Digital presenceDr.Max Polska financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dr.Max Polska leadership team
Management profileNumber of profiles
Dr.Max Polska funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dr.Max Polska M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dr.Max Polska
What does Dr.Max Polska do?
Dr.Max Polska operates a franchise pharmacy network of more than 540 locations across Poland, dispensing prescription and over-the-counter medications, providing health consultations, and selling health products directly to consumers. The network is supported by ViaPharma pharmaceutical wholesale operations and an integrated e-commerce platform for online medication orders with home delivery.
Is Dr.Max Polska a public or private company?
Dr.Max Polska is a private company. It is classified as unknown and is currently operating.
When was Dr.Max Polska founded?
Dr.Max Polska was founded in 2006. It employs 501 to 1,000 people.
Where is Dr.Max Polska based?
Dr.Max Polska is headquartered in Wrocław, dolnośląskie, Poland, in the Europe region.
How does Dr.Max Polska make money?
Three revenue lines are on record. Pharmacy Retail Operations are the primary driver. The others are pharmaceutical Wholesale and online Pharmacy Sales.
Does Dr.Max Polska have an API?
No public API is recorded for Dr.Max Polska.
What industry is Dr.Max Polska in?
Dr.Max Polska's product category is Retail Pharmacy. Its primary akta.pro industry code is HLAFALAA, Retail & Community Pharmacies (Chain/Independent), with a secondary code of HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its NAICS code is 456110 and its SIC code is 5912.